Nos publications

Les équipes du CRCM publient chaque année plus de 130 articles de recherche fondamentale, translationnelle et clinique.

En direct

Géraldine Guasch (CRCM) - Publication dans Nature Communications -

Photo de profil par défault
Jan 2021 Methods in molecular biology (Clifton, N.J.)

Identification of PDZ Interactions by Affinity Purification and Mass Spectrometry Analysis.

Daulat AM, Audebert S, Wagner M, Camoin L, Borg JP

Photo de profil par défault
Jan 2021 Cancers

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2 γδ T Cell Alterations with Lymph Node Invasion.

Fattori S, Gorvel L, Granjeaud S, Rochigneux P, Rouvière MS, Ben Amara A, Boucherit N, Paul M, Dauplat MM, Thomassin-Piana J, Paciencia-Gros M, Avenin M, Pakradouni J, Barrou J, Charafe-Jauffret E, Houvenaeghel G, Lambaudie E, Bertucci F, Goncalves A, Tarpin C, Nunès JA, Devillier R, Chretien AS, Olive D

Nov 2020 Frontiers in Oncology

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer.

Bertucci A, Bertucci F, Zemmour C, Lerebours F, Pierga JY, Levy C, Dalenc F, Grenier J, Petit T, Berline M, Gonçalves A

Photo de profil par défault
Nov 2020 Oncogene

The Scribble family in cancer: twentieth anniversary.

Santoni MJ, Kashyap R, Camoin L, Borg JP

Photo de profil par défault
Nov 2020 Journal of hepatology

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

Arechederra M, Bazai SK, Abdouni A, Sequera C, Mead TJ, Richelme S, Daian F, Audebert S, Dono R, Lozano A, Gregoire D, Hibner U, Allende DS, Apte SS, Maina F

Photo de profil par défault
Nov 2020 Journal for immunotherapy of cancer

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.

Shigeta K, Matsui A, Kikuchi H, Klein S, Mamessier E, Chen IX, Aoki S, Kitahara S, Inoue K, Shigeta A, Hato T, Ramjiawan RR, Staiculescu D, Zopf D, Fiebig L, Hobbs GS, Quaas A, Dima S, Popescu I, Huang P, Munn LL, Cobbold M, Goyal L, Zhu AX, Jain RK, Duda DG

Photo de profil par défault
Nov 2020 The Journal of biological chemistry

The Ig-like domain of Punctin/MADD-4 is the primary determinant for interaction with the ectodomain of neuroligin NLG-1.

Platsaki S, Zhou X, Pinan-Lucarré B, Delauzun V, Tu H, Mansuelle P, Fourquet P, Bourne Y, Bessereau JL, Marchot P

Photo de profil par défault
Oct 2020 Nature chemistry

CD44 regulates epigenetic plasticity by mediating iron endocytosis.

Müller S, Sindikubwabo F, Cañeque T, Lafon A, Versini A, Lombard B, Loew D, Wu TD, Ginestier C, Charafe-Jauffret E, Durand A, Vallot C, Baulande S, Servant N, Rodriguez R

Photo de profil par défault
Oct 2020 Molecular oncology

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.

Ariey-Bonnet J, Carrasco K, Le Grand M, Hoffer L, Betzi S, Feracci M, Tsvetkov P, Devred F, Collette Y, Morelli X, Ballester P, Pasquier E

Photo de profil par défault
Oct 2020 European journal of medicinal chemistry

Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.

Cavalier JF, Spilling CD, Durand T, Camoin L, Canaan S